secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001703057-25-000032
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera dismisses KPMG, appoints EY as auditor for FY2026 after tender
------------------------------------------------------------------------

- Audit Committee dismissed KPMG effective after 2025 audit; no disagreements or reportable events in 2023-2025.
- EY selected as new independent auditor for FY2026 following a formal tender process.
- KPMG's audit opinions for FY2023 and FY2024 were unqualified with no adverse opinions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000170305725000032/0001703057-25-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000170305725000032/abcl-20251124.htm
  HTML page:      https://secwatch.observer/filing/0001703057-25-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer